SI-BONE Sees Robust Demand and Increasing Utilization
The company grew in the mid-teens for the second quarter of 2022, attaining the most active surgeons in company history....
The company grew in the mid-teens for the second quarter of 2022, attaining the most active surgeons in company history....
The company declined in the high teens for 2Q22 as it works to establish new baselines for its sales geographies...
The web-based platform allows for review of a 3D pre-operative planning of the reconstruction of the ankle pathology....
A multi-center collaboration will develop and validate AI algorithms for use in detection of undiagnosed osteopenia and osteoporosis....
The company declined in the low-single digits in 2Q22 as hospital staffing pressures impacted case volumes for complex spine procedures....
The company grew over +20% in 2Q22, bolstered by revenue contributions from recently acquired Pega Medical and MD Orthopedics....
The resulting business will broaden and derisk Bone Therapeutics' portfolio thata targets a broad array of inflammatory and orthopedic indications....
Regenexx published its randomized controlled trial (RCT) mid-term results showing primary anterior cruciate ligament (ACL) healing without the need for...
The parties have amended various agreements, including the distribution agreements for spinal implants and biologics....
AxioMed will be the first lumbar viscoelastic total disc replacement company to complete a U.S. IDE clinical trial....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.